in this issue
People & Business :: Corporate Social Responsibility
Australia Warns of Tainted Batches of Heparin
10:24 AM MDT | April 7, 2008 | Alex Scott
Authorities in Australia have warned that four batches of AstraZeneca’s (AZ) blood-thinning drug heparin are contaminated. AZ is the latest in a series of companies, including Baxter Healthcare (Deerfield, IL), that has identified contamination in its heparin products, and all of the companies source their heparin active pharma ingredients (APIs) from China. Regulatory bodies in Denmark, France, Italy, Japan, Switzerland, and the U.S. say they have removed heparin from their markets to protect patients. Australia’s regulatory agency for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee